HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ferryl iron (Fe(4+))

Also Known As:

Fe(4+); iron(IV); ferryl ion; iron (4+) ion

Networked: 19 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Metals: 20694
  - Heavy Metals: 3207
    - Iron: 47923
      - ferryl iron: 19
- Elements: 18681
  - Heavy Metals: 3207
    - Iron: 47923
      - ferryl iron: 19
  - Transition Elements: 3
    - Iron: 47923
      - ferryl iron: 19

Experts

1.	Rostoker, Guy: 2 articles (07/2019 - 07/2014)
2.	Kozłowska, Bogna: 1 article (02/2022)
3.	Kołsut, Piotr: 1 article (02/2022)
4.	Kraj, Leszek: 1 article (02/2022)
5.	Kruszewski, Marcin: 1 article (02/2022)
6.	Leszek, Przemysław: 1 article (02/2022)
7.	Lewicki, Sławomir: 1 article (02/2022)
8.	Palusińska, Małgorzata: 1 article (02/2022)
9.	Sochanowicz, Barbara: 1 article (02/2022)
10.	Szymański, Łukasz: 1 article (02/2022)

Related Diseases

1.	Nephrogenic Fibrosing Dermopathy 01/01/2013 - "The purpose of the study was to evaluate the efficacy of imatinib mesylate in the treatment of nephrogenic systemic fibrosis (NSF) in a rat model administered high-dose gadodiamide, erythropoietin (Epo) and intravenous iron (IV iron). "
2.	Hypotension (Low Blood Pressure) 01/01/2019 - "Quality of life was reported in five studies with four reporting no difference between treatment groups and one reporting improvement in participants treated with IV iron.IV iron compared with oral iron may increase the numbers of participants, who experience allergic reactions or hypotension (15 studies, 2607 participants: RR 3.56, 95% CI 1.88 to 6.74) (absolute harm: 24 per 1000 with IV iron versus 7 per 1000) but may reduce the number of participants with all gastrointestinal adverse effects (14 studies, 1986 participants: RR 0.47, 95% CI 0.33 to 0.66) (absolute benefit: 150 per 1000 with IV iron versus 319 per 1000). "
3.	Hypersensitivity (Allergy) 01/01/2019 - "Quality of life was reported in five studies with four reporting no difference between treatment groups and one reporting improvement in participants treated with IV iron.IV iron compared with oral iron may increase the numbers of participants, who experience allergic reactions or hypotension (15 studies, 2607 participants: RR 3.56, 95% CI 1.88 to 6.74) (absolute harm: 24 per 1000 with IV iron versus 7 per 1000) but may reduce the number of participants with all gastrointestinal adverse effects (14 studies, 1986 participants: RR 0.47, 95% CI 0.33 to 0.66) (absolute benefit: 150 per 1000 with IV iron versus 319 per 1000). "
4.	Iron Overload 07/01/2014 - "The realization of a quantitative hepatic MRI to evaluate iron overload and monitor the treatment by iron IV must also be considered on a case by case basis. " 07/01/2014 - "The use of intravenous iron must be more cautious in the future taking into account the results of a recent French study published in the American Journal of Medicine showing the high frequency of iron overload at quantitative hepatic MRI among haemodialysis patients receiving iron IV following the current guidelines. "
5.	Anemia 07/01/2013 - "As the primary outcome for anemia, the dose of ESAs was recorded at 4-month intervals and the monthly dose of intravenous iron (IV Fe) was reported. " 01/01/2016 - "In the preoperative setting, administration of oral iron, IV iron, or ESA alone or in combination to correct underlying anemia led to significantly reduced transfusion rates. " 07/01/2008 - "Intravenous iron (IV Fe) as an adjunct to therapy with erythropoiesis- stimulatory agents (ESAs) is standard care in dialysis-associated anemia, adding huge increments in hemoglobin and hematopoietic responses and decreased transfusions without significant toxicity. " 11/01/2007 - "Anemia prevention for hemodialysis relies primarily on supplemental erythropoietin (EPO) and intravenous iron (IV-iron). "

Related Drugs and Biologics

1.	Iron
2.	Erythropoietin
3.	Imatinib Mesylate (Gleevec)
4.	gadodiamide (Omniscan)
5.	Hepcidins
6.	Oxidants (Oxidizing Agents)
7.	Transferrin (beta 2 Transferrin)
8.	Thallium
9.	Surface-Active Agents (Surfactants)
10.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Therapeutics
2.	Renal Dialysis (Hemodialysis)